President’s address: Treatment of tamoxifen-refractory breast cancer — approach by animal models.
- Published in:
- 2001
- By:
- Publication type:
- Editorial
Works matching IS 13406868 AND DT 2001 AND VI 8 AND IP 4
Results: 15
1
2
New strategies for the treatment of breast cancer.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 265, doi. 10.1007/BF02967523
- By:
- Publication type:
- Article
3
Treatment selection in ductal carcinoma in situ.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 275, doi. 10.1007/BF02967524
- By:
- Publication type:
- Article
4
Well differentiated clinging carcinoma and atypical ductal hyperplasia are synonymous.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 283, doi. 10.1007/BF02967525
- By:
- Publication type:
- Article
5
E1A: Tumor suppressor or oncogene? Preclinical and clinical investigations of E1A gene therapy.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 285, doi. 10.1007/BF02967526
- By:
- Publication type:
- Article
6
International consensus meeting on the treatment of primary breast cancer 2001, St. Gallen, Switzerland.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 294, doi. 10.1007/BF02967527
- By:
- Publication type:
- Article
7
Aromatase and aromatase inhibitors.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 329, doi. 10.1007/BF02967533
- By:
- Publication type:
- Article
8
Resistant mechanisms of anthracyclines — pirarubicin might partly break through the P-glycoprotein-mediated drug-resistance of human breast cancer tissues.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 333, doi. 10.1007/BF02967534
- By:
- Publication type:
- Article
9
Adjuvant therapy for breast cancer — results from the USA consensus conference.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 298, doi. 10.1007/BF02967528
- By:
- Publication type:
- Article
10
Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab).
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 316, doi. 10.1007/BF02967531
- By:
- Publication type:
- Article
11
The worldwide perspective in the adjuvant treatment of primary lymph node positive breast cancer.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 321, doi. 10.1007/BF02967532
- By:
- Publication type:
- Article
12
Evolution of breast cancer management: Focus on neoadjuvant chemotherapy.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 339, doi. 10.1007/BF02967535
- By:
- Publication type:
- Article
13
Third-generation aromatase inhibitors in the treatment of advanced breast cancer.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 305, doi. 10.1007/BF02967529
- By:
- Publication type:
- Article
14
Compassionate use of humanized anti-HER2/ neu protein, trastuzumab for metastatic breast cancer in Japan.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 310, doi. 10.1007/BF02967530
- By:
- Publication type:
- Article
15
3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: Clinical results and future perspectives with reference to FDG-PET.
- Published in:
- Breast Cancer (13406868), 2001, v. 8, n. 4, p. 351, doi. 10.1007/BF02967536
- By:
- Publication type:
- Article